home / stock / rani / rani news

RANI News and Press, Rani Therapeutics Holdings Inc. From 06/05/23

Stock Information
Company Name: Rani Therapeutics Holdings Inc.
Stock Symbol: RANI
Market: NASDAQ
Website: ranitherapeutics.com
Menu
RANI RANI Quote RANI Short RANI News RANI Articles RANI Message Board
Get RANI Alerts

News, Short Squeeze, Breakout and More Instantly...
RANI - Rani Therapeutics and Celltrion Expand Partnership to Include Adalimumab Biosimilar for RT-105

SAN JOSE, Calif., June 05, 2023 (GLOBE NEWSWIRE) -- Rani Therapeutics Holdings, Inc. (“Rani Therapeutics” or “Rani”) (Nasdaq: RANI), a clinical-stage biotherapeutics company focused on the oral delivery of biologics and drugs, today announced that it has expanded its p...
RANI - Rani Therapeutics to Present at the Jefferies Healthcare Conference

SAN JOSE, Calif., June 01, 2023 (GLOBE NEWSWIRE) -- Rani Therapeutics Holdings, Inc. (“Rani Therapeutics” or “Rani”) (Nasdaq: RANI), a clinical-stage biotherapeutics company focused on the oral delivery of biologics and drugs, today announced the company’s Chief...

RANI - Rani Therapeutics Announces Acceptance of Three Abstracts for Presentation at ENDO 2023 Annual Conference

SAN JOSE, Calif., May 31, 2023 (GLOBE NEWSWIRE) -- Rani Therapeutics Holdings, Inc. (“Rani Therapeutics” or “Rani”) (Nasdaq: RANI), a clinical-stage biotherapeutics company focused on the oral delivery of biologics and drugs, today announced that three submitted abstra...

RANI - Rani Therapeutics Appoints Kate McKinley as Chief Business Officer

SAN JOSE, Calif., May 24, 2023 (GLOBE NEWSWIRE) -- Rani Therapeutics Holdings, Inc. (“Rani Therapeutics” or “Rani”) (Nasdaq: RANI), a clinical-stage biotherapeutics company focused on the oral delivery of biologics and drugs, today announced that it has appointed Kate ...
RANI - Rani Therapeutics GAAP EPS of -$0.33 beats by $0.10

2023-05-10 17:46:18 ET Rani Therapeutics press release ( NASDAQ: RANI ): Q1 GAAP EPS of -$0.33 beats by $0.10 . Cash, cash equivalents and marketable securities as of March 31, 2023 totaled $86.8 million, compared to cash, cash equivalents and marketable securities of ...

RANI - Rani Therapeutics Reports First Quarter 2023 Financial Results; Provides Corporate Update

- Announced partnership with Celltrion on development of RT-111, a RaniPill GO capsule containing a biosimilar for the monoclonal antibody ustekinumab - - Received preliminary feedback from FDA on RT-102 development plans; 505(b)(2) pathway for RT-102 could be suitable - - Initi...

RANI - Rani Therapeutics: Novel Drug Delivery System, Under-Covered And Early Stage

2023-05-05 17:33:19 ET Summary Rani Therapeutics Holdings, Inc. has an exciting oral drug delivery system for biologics. It has shown excellent early data in trials. However, the Rani Therapeutics Holdings, Inc. system is very early stage right now. Rani Therapeutics...
RANI - Rani Therapeutics to Participate in the H.C. Wainwright BioConnect Investor Conference at NASDAQ

SAN JOSE, Calif., April 25, 2023 (GLOBE NEWSWIRE) -- Rani Therapeutics Holdings, Inc. (“Rani Therapeutics” or “Rani”) (Nasdaq: RANI), a clinical-stage biotherapeutics company focused on the oral delivery of biologics and drugs, today announced the company’s Chie...

RANI - Rani Therapeutics to Present at the 22nd Annual Needham Virtual Healthcare Conference

SAN JOSE, Calif., April 11, 2023 (GLOBE NEWSWIRE) -- Rani Therapeutics Holdings, Inc. (“Rani Therapeutics” or “Rani”) (Nasdaq: RANI), a clinical-stage biotherapeutics company focused on the oral delivery of biologics and drugs, today announced the company’s Chie...

RANI - Rani Therapeutics Holdings, Inc. (RANI) Q4 2022 Earnings Call Transcript

2023-03-22 18:43:05 ET Rani Therapeutics Holdings, Inc. (RANI) Q4 2022 Earnings Conference Call March 22, 2023, 04:30 PM ET Company Participants Laurence Watts - Managing Director, Gilmartin Group LLC Talat Imran - CEO Svai Sanford - CFO Mir Hashim - Chief Sc...
Previous 10 Next 10